Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Paul Geerts"'
Publikováno v:
Pilot and Feasibility Studies, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract Background Patients with multiple myeloma (MM) increasingly face complicated treatment regimens. E-health may support patients and healthcare providers in enhancing a patient-centered healthcare approach. Therefore, we aimed to develop a pat
Externí odkaz:
https://doaj.org/article/3d42ab48f95341a88fe82a598185b5aa
Autor:
Flore Decuypere, Jan Sermon, Paul Geerts, Tom R Denee, Cedric De Vos, Bart Malfait, Mark Lamotte, Cornelis L Mulder
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179049 (2017)
Achieving greater continuation of treatment is a key element to improve treatment outcomes in schizophrenia patients. However, reported treatment continuation can differ markedly depending on the study design. In a retrospective setting, treatment co
Externí odkaz:
https://doaj.org/article/a19dba64ae03457abb03d671e385a250
Autor:
Sem Geertsema, Paul Geertsema, Lyanne M. Kieneker, Amaal E. Abdulle, Sacha la Bastide-van Gemert, Stephan J.L. Bakker, Robin P.F. Dullaart, Gerard Dijkstra, Ron T. Gansevoort, Klaas Nico Faber, Harry van Goor, Arno R. Bourgonje
Publikováno v:
Redox Biology, Vol 77, Iss , Pp 103408- (2024)
Background: Chronic Kidney Disease (CKD), is often detected late due to its asymptomatic nature in the early stage of the disease. Overproduction of reactive oxygen species contributes to various pathological processes through oxidative stress (OS),
Externí odkaz:
https://doaj.org/article/52210a27e2d548f083e62c515b0ee5bd
Publikováno v:
Kidney Medicine, Vol 6, Iss 5, Pp 100821- (2024)
Externí odkaz:
https://doaj.org/article/85b09a4579194338907c07d6a225e3e4
Publikováno v:
CNS Drugs. 29:637-658
Although continuous treatment with antipsychotics is still recommended as the gold standard treatment paradigm for all patients with schizophrenia, some clinicians question whether continuous antipsychotic treatment is necessary, or even justified, f
Autor:
Tom R. Denee, Jan Sermon, Cedric De Vos, Flore Decuypere, Cornelis L. Mulder, Bart Malfait, Mark Lamotte, Paul Geerts
Publikováno v:
PLoS ONE
PLoS One (print), 12(6):e0179049. Public Library of Science
PLoS ONE, Vol 12, Iss 6, p e0179049 (2017)
PLoS One (print), 12(6):e0179049. Public Library of Science
PLoS ONE, Vol 12, Iss 6, p e0179049 (2017)
Achieving greater continuation of treatment is a key element to improve treatment outcomes in schizophrenia patients. However, reported treatment continuation can differ markedly depending on the study design. In a retrospective setting, treatment co
Publikováno v:
Early Intervention in Psychiatry. 8:39-49
Aim: Potential differences in psychiatric clinical outcomes and hospitalization rates before and after the initiation of long-acting risperidone among recently and long-term diagnosed schizophrenia patients were studied. Methods: Data from two observ
Autor:
Cornelis L. Mulder, Paul Geerts, F. Decuypere, C Widrich, R. Rijntjes, Tom R. Denee, Jan Sermon
Publikováno v:
Value in Health, 18(7):A407. Elsevier Ltd.
Autor:
P. Richard Harrigan, Sharyne M. Donfield, Douglas A. Jabs, Mikhail Rotkevich, Pavel Dobrynin, Holli H. Dilks, Edward D. Gomperts, Nikolay Cherkasov, Stephen J. O'Brien, Paul Geerts, Efe Sezgin, Sergey V. Malov, Mark L. Van Natta, Jennifer L. Troyer, Li Guan, Zabrina L. Brumme, Anton Svitin, Taras K. Oleksyk, Andrey Shevchenko, Sher L. Hendrickson
Publikováno v:
GigaScience
Background: As genome-wide sequence analyses for complex human disease determinants are expanding, it is increasingly necessary to develop strategies to promote discovery and validation of potential disease-gene associations. Findings: Here we presen
Publikováno v:
Value in Health. 17(7)